Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is Cannabis Used by Psychiatrists for Treatment-Resistant Mood Disorders? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The views of psychiatrists on cannabis for treatment-resistant cases are mixed, reflecting both cautious optimism and ongoing concern. Some psychiatrists consider cannabis, particularly CBD, for patients who do not respond to conventional antidepressants or mood stabilisers. However, this is far from standard practice, as evidence remains limited and cannabis is rarely included in formal guidelines for mood disorders. 

In clinical reality, most psychiatrists are hesitant to prescribe cannabis due to regulatory restrictions and a lack of large-scale trials. Where it is used, it is generally within private settings, with careful oversight to reduce risks. 

Can I use Medical Cannabis for Pain Relief?

Psychiatric Approaches to Cannabis Prescribing 

Research into psychiatrists on cannabis for treatment-resistant depression and related conditions highlights how it is viewed in practice. 

Clinical Practice 

In current clinical practice, cannabis is sometimes explored as an option for patients who have tried multiple medications without success. Even then, it is seen as experimental. 

Off-Label Use 

Some psychiatrists consider off-label use of cannabis-based medicines, especially CBD-dominant products, for anxiety, insomnia, or persistent depression. This remains highly individualised. 

Specialist Prescribing 

Most access occurs through specialist prescribing in private clinics, where psychiatrists with the necessary authority assess whether cannabis is appropriate for a complex mental health condition.

In summary, while some psychiatrists on cannabis for treatment-resistant patients show cautious interest, cannabis remains far from a mainstream option. Its use is generally limited to exceptional cases under strict supervision. 

For individuals considering whether psychiatric care might involve cannabis, providers like LeafEase can offer supportive consultations tailored to safe and professional guidance. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories